Clinical Trial Update: Targeted Drug Combined With CHOP in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating a targeted drug combined with CHOP for newly diagnosed peripheral T-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Snippet

Sponsor: Ruijin Hospital | Conditions: Peripheral T-cell Lymphoma | Phase 2 | Status: UNKNOWN